Navigation Links
CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
Date:1/22/2009

ORLANDO, Fla., Jan. 22 /PRNewswire/ -- CORD:USE Cord Blood Bank is honored to announce that it has been accredited by the Foundation for the Accreditation of Cellular Therapy ("FACT"). CORD:USE is a leading public cord blood bank that specializes in the collection, processing, storage and distribution of donated cord blood. Cord blood has already been used for transplantation in more than 14,000 patients with over 70 life-threatening diseases such as leukemia, lymphoma, thalassemia, and sickle cell anemia.

"The Accreditation by FACT is an important milestone for CORD:USE," says Dr. Edward Guindi, President and CEO of CORD:USE Cord Blood Bank. "Obtaining FACT Accreditation for cord blood collection, processing, testing, banking, selection and release of unrelated allogeneic cord blood units validates the high quality procedures which CORD:USE and our world-class team utilize. This accreditation gives additional assurance to transplant physicians when choosing our units for their patients."

FACT is considered by many transplanters to be the premier accreditation organization in the cord blood banking industry. FACT is a non-profit, voluntary organization that develops, maintains and updates comprehensive standards for all aspects of cord blood collection, processing and transplantation. The process includes an examination and inspection from international panels of cord blood experts and at least one transplant physician. The examination team reviews all aspects of the cord blood banking process. Only those companies with consistent, well-documented processes that meet the standards developed by FACT in all areas are eligible for accreditation.

"We are extremely proud to be one of the elite cord blood banks worldwide who has met the stringent processes standards required for FACT accreditation and that provides the highest quality cord blood units for patients in need of potentially life-saving transplants," says Dr. Guindi.

About CORD:USE Cord Blood Bank

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit www.corduse.com.


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... AlignLife clinics nationwide are giving back to their communities by collecting ... bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the ... , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the ... and Your Health on Voice of America, declared on her radio program in November ... the fact that when these bullies attack leaders in corporate America, they are trying ...
(Date:12/7/2016)... ... , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals ... To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® ... Deals on Botox® and Juvederm® just in time for the holiday party season. ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016 According to responses from U.S. oncologists that ... of patients with non-small cell lung cancer (NSCLC), treatment decisions ... genetic mutation status. The findings of the survey were presented ... #P3.02b ) at the 2016 World Conference on Lung ... The survey results revealed an overall high rate of ...
(Date:12/7/2016)... Dec. 7, 2016 Boehringer Ingelheim today ... patients with unresectable malignant pleural mesothelioma (MPM) met ... data, presented at the 17 th IASLC ... Vienna , showed nintedanib plus pemetrexed/cisplatin demonstrated ... pemetrexed/cisplatin, with a significantly improved PFS (9.4 vs ...
(Date:12/7/2016)... YORK , December 7, 2016 ... Pharmaceuticals PLC (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. ... DNAI ), and AveXis Inc. (NASDAQ: AVXS ... Sector Index fell roughly 37% to reach a level equal ... it is down by approximately 14% for the year, it ...
Breaking Medicine Technology: